Advertisement
Home »

CEASE-AF Meets Primary Endpoint in Persistent AF

Apr 25, 2023

REFERENCES & ADDITIONAL READING

Doll N, et al. Effectiveness and safety of hybrid epicardial and endocardial ablation versus endocardial ablation in patients with persistent and longstanding persistent atrial fibrillation: Primary results of the CEASE-AF trial. Late-Breaking Science Day 2, EHRA 2023, 16–18 April, Barcelona, Spain.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement